JBS - JBS N.V. Stock Analysis | Stock Taper
Logo
JBS N.V.

JBS

JBS N.V. NYSE
$17.65 -0.56% (-0.10)

Market Cap $39.37 B
52w High $18.65
52w Low $12.37
Dividend Yield 9.87%
Frequency Monthly
P/E 9.34
Volume 3.25M
Outstanding Shares 2.22B

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $126.27B $10.08B $2.27B 1.8% $2.25 $8.59B
Q3-2025 $120.55B $9.35B $3.1B 2.57% $0.52 $11.47B
Q2-2025 $118.97B $9.78B $3.04B 2.55% $1.37 $7.78B
Q1-2025 $114.13B $10.18B $2.92B 2.56% $1.32 $9.61B
Q4-2024 $116.7B $11.75B $2.41B 2.07% $1.09 $9.37B

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $25.98B $248.34B $195.97B $47.87B
Q3-2025 $3.56B $44.19B $34.68B $8.72B
Q2-2025 $13.67B $228.12B $177.73B $45.88B
Q1-2025 $27.71B $239.48B $192.07B $43.31B
Q4-2024 $34.76B $251.94B $201.57B $44.78B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $2.27B $10.66B $-4.76B $-307.92M $5.64B $6B
Q3-2025 $587.23M $1.06B $-584.13M $680.6M $1.05B $542.79M
Q2-2025 $3.04B $2.94B $-3.48B $-13.03B $-14.04B $389.59M
Q1-2025 $2.92B $-3.24B $-1.42B $-204.28M $-7.05B $-4.79B
Q4-2024 $2.41B $9B $-2.88B $-2.58B $3.29B $5.9B

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at JBS N.V.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

JBS combines a massive global revenue base, solid operating profitability, and strong cash generation with a wide geographic and product footprint. Its scale, vertical integration, and established brands provide meaningful competitive advantages. The asset base is substantial, liquidity is generally supportive, and the company continues to invest heavily in its operations and in new technologies, including alternative proteins and advanced processing. Together, these factors underpin its position as a key player in global food supply.

! Risks

The most notable risks are high leverage, thin net margins, and exposure to volatile and highly scrutinized meat markets. Elevated debt and interest costs limit financial flexibility and magnify the impact of downturns or shocks. The business also faces ongoing ESG, regulatory, and reputational challenges tied to environmental impact, animal welfare, and labor practices. In addition, long-term shifts toward plant-based or lower-meat diets, intensified competition, and execution risks in new technologies like cultivated meat could all weigh on future performance.

Outlook

Based on the available information, JBS looks like a mature, stable operator with robust operational cash flows and a clear strategy to modernize and diversify its protein offerings. The outlook appears balanced: its scale, investment in efficiency, and moves into higher-value and alternative products support resilience, while leverage, sector volatility, and ESG pressures remain important headwinds. Future performance will likely hinge on disciplined debt management, sustained operational excellence, and the company’s ability to turn its innovation agenda—especially in value-added and new proteins—into durable, profitable growth.